Protocol for MAAESTRO: Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment-A Randomized Crossover Study of an Educational and Reminder-Based Intervention in Ischemic STROke Patients Under Polypharmacy

Alexandros A Polymeris, Valerie Albert, Kurt E Hersberger, Stefan T Engelter, Sabine Schaedelin, Isabelle Arnet, Philippe A Lyrer, Alexandros A Polymeris, Valerie Albert, Kurt E Hersberger, Stefan T Engelter, Sabine Schaedelin, Isabelle Arnet, Philippe A Lyrer

Abstract

Background: Non-adherence to direct oral anticoagulants (DOACs) remains a matter of concern, especially for patients with a recent stroke. However, data on electronically monitored adherence and adherence-improving interventions are scarce. Aims: We aim to use electronic monitoring in DOAC-treated stroke patients to (i) evaluate the effect of an educational, reminder-based adherence-improving intervention, (ii) investigate predictors of non-adherence, (iii) identify reliable self-report measures of adherence, and (iv) explore the association of non-adherence with clinical outcomes. Methods: Single-center, randomized, crossover, open-label study. Adherence to DOACs of polymedicated patients self-administering their medication will be monitored electronically throughout the 12-month-long study following hospitalization for ischemic stroke. After a 6-month observational phase, patients will receive pharmaceutical counseling with feedback on their intake history and be given a multi-compartment pillbox for the subsequent 6-month interventional phase. The pillbox will provide intake reminders either during the first or the last three interventional-phase months. Patients will be randomly allocated to reminders-first or reminders-last. Study outcomes: Primary: non-optimal timing adherence; Secondary: non-optimal taking adherence; timing adherence; taking adherence; self-reported adherence; clinical outcomes including ischemic and hemorrhagic events; patient-reported device usability and satisfaction. Sample size estimates: A sample of 130 patients provides 90% power to show a 20% improvement of the primary adherence outcome with intake reminders. Discussion: MAAESTRO will investigate various aspects of non-adherence and evaluate the effect of an adherence-improving intervention in DOAC-treated patients with a recent stroke using electronic monitoring. Clinical Trial Registration: ClinicalTrials.gov identifier: NCT03344146, Swiss National Clinical Trials Portal SNCTP000002410.

Keywords: adherence; adherence-improving intervention; direct oral anticoagulants; electronic monitoring; ischemic stroke; multi-compartment compliance aid; polypharmacy.

Figures

Figure 1
Figure 1
Study flowchart.

References

    1. Borne RT, O'Donnell C, Turakhia MP, Varosy PD, Jackevicius CA, Marzec LN, et al. . Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration. BMC Cardiovasc Disord.(2017) 17:236. 10.1186/s12872-017-0671-6
    1. Emren SV, Senoz O, Bilgin M, Beton O, Aslan A, Taskin U, et al. . Drug adherence in patients with nonvalvular atrial fibrillation taking non-vitamin k antagonist oral anticoagulants in Turkey. Clin Appl Thromb Hemost. (2018) 24:525–31. 10.1177/1076029617693940
    1. Polymeris AA, Traenka C, Hert L, Seiffge DJ, Peters N, De Marchis GM, et al. . Frequency and determinants of adherence to oral anticoagulants in stroke patients with atrial fibrillation in clinical practice. Eur Neurol. (2016) 76:187–93. 10.1159/000450750
    1. Sutton S, Kinmonth AL, Hardeman W, Hughes D, Boase S, Prevost AT, et al. . Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med. (2014) 48:293–9. 10.1007/s12160-014-9595-x
    1. Desteghe L, Vijgen J, Koopman P, Dilling-Boer D, Schurmans J, Dendale P, et al. . Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation. Eur Heart J. (2018) 39:1394–403. 10.1093/eurheartj/ehx762
    1. Boehme P, Wienand P, Herrmann M, Truebel H, Mondritzki T. New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next century. Med Hypotheses (2017) 108:46–50. 10.1016/j.mehy.2017.07.034
    1. Al AlShaikh S, Quinn T, Dunn W, Walters M, Dawson J. Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: a systematic review and meta-analyses. Eur Stroke J (2016) 1:65–75. 10.1177/2396987316647187
    1. Labovitz DL, Shafner L, Reyes Gil M, Virmani D, Hanina A. Using artificial intelligence to reduce the risk of nonadherence in patients on anticoagulation therapy. Stroke (2017) 48:1416–9. 10.1161/STROKEAHA.116.016281
    1. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. (2005) 53:695–9. 10.1111/j.1532-5415.2005.53221.x
    1. Noens L, van Lierde MA, De Bock R, Verhoef G, Zachee P, Berneman Z, et al. . Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood (2009) 113:5401–11. 10.1182/blood-2008-12-196543
    1. Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci. (2009) 31:426–31. 10.1007/s11096-009-9296-x
    1. Allemann SS, Hersberger HK, Arnet I. Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting. Integ Pharm Res Pract. (2015) 4:167–74. 10.2147/IPRP.S90923
    1. Messerli M, Blozik E, Vriends N, Hersberger KE. Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy–a prospective randomised controlled trial. BMC Health Serv Res. (2016) 16:145. 10.1186/s12913-016-1384-8
    1. Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS. Electronic medication packaging devices and medication adherence: a systematic review. JAMA (2014) 312:1237–47. 10.1001/jama.2014.10059

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren